icon
icon
icon
icon
Upgrade
Upgrade

News /

Articles /

Lifetime Brands: GLP-1, Weight Loss Livestream Event

Market VisionMonday, Sep 23, 2024 3:30 pm ET
1min read
Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer, and marketer of branded consumer products used in the home, is set to host a complimentary livestream event focused on GLP-1 agonists and weight loss on September 25. The event, titled "GLP-1 and Weight Loss Drugs: The Future of Obesity Management," will feature the company's Chief Science Officer and a panel of experts in the field.

The event aims to address the role of GLP-1 agonists in weight loss and management, presenting the latest research and clinical trials on these drugs. The panelists will also discuss potential side effects and risks associated with GLP-1 agonists, ensuring a comprehensive and well-rounded discussion.

The focus on GLP-1 and weight loss drugs aligns with current market trends and investor interests, as the global weight loss drugs market is expected to reach $13.4 billion by 2027, growing at a CAGR of 6.6% during the forecast period. The complimentary nature of the event will also increase its accessibility and potential reach to a wider audience of investors.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.